{"id":140587,"date":"2023-02-08T14:43:41","date_gmt":"2023-02-08T19:43:41","guid":{"rendered":"https:\/\/44.250.171.167\/?p=140587"},"modified":"2023-02-08T14:43:42","modified_gmt":"2023-02-08T19:43:42","slug":"sun-pharmaceutical-q3fy23-3-growth-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sun-pharmaceutical-q3fy23-3-growth-in-profits\/","title":{"rendered":"Sun Pharmaceutical Q3FY23; 3% Growth in Profits"},"content":{"rendered":"\n

Sun Pharmaceutical Industries Limited<\/a>\u2019s revenue in Q3FY23 rose 14% to \u20b9 112,410 millions. Consolidated Profit After Tax came at \u20b9 21,808 millions in Q3FY23 showcasing a 3% rise on an YoY basis. In this quarter\u2019s\u00a0results<\/a>, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q3Y23.<\/p>\n\n\n\n

\"\"<\/a><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"

Sun Pharmaceutical Industries Limited\u2019s revenue in Q3FY23 rose 14% to \u20b9 112,410 millions. Consolidated Profit After Tax came at \u20b9 21,808 millions in Q3FY23 showcasing a 3% rise on an YoY basis. In this quarter\u2019s\u00a0results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in […]<\/p>\n","protected":false},"author":1885,"featured_media":140588,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10162],"class_list":["post-140587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-SUNPHARMA.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":143110,"url":"https:\/\/alphastreet.com\/india\/sun-pharma-advanced-research-q3fy23-earnings\/","url_meta":{"origin":140587,"position":0},"title":"Sun Pharma Advanced Research Q3FY23 Earnings","author":"Karan_Singh","date":"March 1, 2023","format":false,"excerpt":"(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters of losses, Sun Pharma Advanced Research Company\u00a0declared a net profit of Rs. 10.15 crore for the months of October through December, turning a profit once more. Over the same time\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":141465,"url":"https:\/\/alphastreet.com\/india\/panacea-biotec-q3fy23-26-fall-in-revenue\/","url_meta":{"origin":140587,"position":1},"title":"Panacea Biotec Q3FY23; 26% Fall in Revenue","author":"Karan_Singh","date":"February 14, 2023","format":false,"excerpt":"Panacea Biotec Limited\u2019s revenue in Q3FY23 fell 26% to \u20b9 11,520 lakhs. Consolidated Profit After Tax came at \u20b9 1,937 lakhs in Q3FY23. In this quarter\u2019s\u00a0results, the reports suggested that the firm has reported decreased revenues and the reason for the increased profitability is the income recieved from Exceptional Items.","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-PANACEABIO.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-PANACEABIO.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-PANACEABIO.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-PANACEABIO.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/Q3FY23-PANACEABIO.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":140791,"url":"https:\/\/alphastreet.com\/india\/lupin-limited-q3fy23-47-growth-in-profits\/","url_meta":{"origin":140587,"position":2},"title":"Lupin Limited Q3FY23; 47% Growth in Profits","author":"Karan_Singh","date":"February 9, 2023","format":false,"excerpt":"Lupin Limited\u2019s revenue in Q3FY23 rose 13% to \u20b9 1,97,66,301 lakhs. Consolidated Profit After Tax came at \u20b9 8,34,871 lakhs in Q3FY23 showcasing a 3,851% rise on an YoY basis. In this quarter\u2019s\u00a0results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":142923,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-limited-q3fy23-earnings-story\/","url_meta":{"origin":140587,"position":3},"title":"Sanofi India Limited Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 27, 2023","format":false,"excerpt":"Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products. Financial Results: The company reported a decline of 2.32% YoY in revenue from operations which stood at INR 671.9 crore in the third quarter of FY23, as compared to INR 687.90 crore in the year-ago quarter. In the\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":139284,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceutical-reports-14-rise-in-its-net-profit-for-q3fy23\/","url_meta":{"origin":140587,"position":4},"title":"Torrent Pharmaceutical reports 14% rise in its net profit for Q3FY23","author":"Chirag Gupta","date":"January 26, 2023","format":false,"excerpt":"Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to INR 283 crore in the third quarter ended December 31, 2022. The drug firm had reported a net profit of INR 249 crore in the October-December period of previous fiscal. Net sales increased to INR\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/f9e2d8fe-3c5a-41de-af28-09727fd365cc.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":140018,"url":"https:\/\/alphastreet.com\/india\/divis-labs-ltd-nsedivislab-q3-fy23-results-outtotal-income-rises-5-yoy\/","url_meta":{"origin":140587,"position":5},"title":"Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy","author":"Divyansh_Kasana","date":"February 3, 2023","format":false,"excerpt":"Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company operates globally, with facilities in India, the United States, and Europe, and serves customers in over 60 countries. Divi's Laboratories is known for its strong focus on quality\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/140587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=140587"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/140587\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/140588"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=140587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=140587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=140587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}